IBD & Tea: what patients want to know when it comes to a clinical trial
Often, patients who live with Inflammatory Bowel Disease (IBD) do [...]
IBD & Tea: Building trust in new treatments & understanding clinical trials
Tina Aswani Omprakash is an award-winning blogger, speaker and patient [...]
The Science Behind New Deal – Video launch!
Over two million people in Europe live with an inflammatory [...]
Small drugs – Big considerations: How New Deal researchers are overcoming the challenges of scaling-up a potential IBD nanomedicine
A great chef could create an outstanding dish that revolutionizes [...]
From the lab to the market: regulations and development of new treatments.
Translating research ideas into prescription medicines is a long journey [...]
COVID-19 and Inflammatory Bowel Disease: an insight into the relationship between conditions
In December 2019 the now named severe acute respiratory syndrome [...]
New Deal News: publications from IDIBAPS and Inserm
This summer has brought good news for the New Deal [...]
A multidisciplinary look into IBDs: EU research projects overview
Medical sciences have gone far in the last decades. Our [...]
Tuning a drug: a glimpse into the process of formulation
In every drug, no matter whether it comes as a [...]
#MakeIBDwork: some useful tips for workers with IBD and their employers
May the 19th is the World IBD Day: a day [...]
